Within the chondrosarcoma TME, cytotoxic CD8+ T cells and CD163+ TAMs represent the two predominant immune populations, predominantly localized at the tumor margins and exerting opposing effects on tumor progression. The gene discussed is CD8A; the disease is neoplasm.